Sabra Healthcare REIT (NASDAQ:SBRA) Price Target Raised to $22.00

Sabra Healthcare REIT (NASDAQ:SBRA – Free Report) had its price objective lifted by Mizuho from $21.00 to $22.00 in a report released on Monday morning,Benzinga reports. They currently have a neutral rating on the real estate investment trust’s stock.

Several other research analysts have also weighed in on the stock. Deutsche Bank reiterated a “buy” rating on shares of Sabra Healthcare REIT in a report on Wednesday, July 22nd. Barclays lowered their target price on shares of Sabra Healthcare REIT from $23.00 to $21.00 and set an “equal weight” rating for the company in a report on Tuesday, October 13th. Citigroup restated a “market outperform” rating on shares of Sabra Healthcare REIT in a report on Wednesday, July 22nd. UBS Group upped their price target on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Wednesday, November 11th. Finally, Weiss Ratings raised shares of Sabra Healthcare REIT from a “hold (c)” rating to a “buy (b-)” rating in a research note on Tuesday, November 3rd. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat.com, Sabra Healthcare REIT presently has an average rating of “Moderate Buy” and an average price target of $21.92.

Get Our Latest Analysis on SBRA

Sabra Healthcare REIT Stock Performance

NASDAQ SBRA opened at $20.62 on Monday. The business’s 50-day moving average price is $19.86 and its 200 day moving average price is $20.07. Sabra Healthcare REIT has a twelve month low of $17.53 and a twelve month high of $22.77. The company has a market capitalization of $5.40 billion, a PE ratio of 73.65, a price-to-earnings-growth ratio of 1.76 and a beta of 0.68. The company has a current ratio of 1.21, a quick ratio of 1.21 and a debt-to-equity ratio of 0.86.

Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last issued its quarterly earnings results on Monday, November 2nd. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.16 by ($0.05). The business had revenue of $249.57 million during the quarter, compared to analyst estimates of $236.64 million. Sabra Healthcare REIT had a return on equity of 2.55% and a net margin of 7.78%. The firm’s quarterly revenue was up 31.4% on a year-over-year basis. During the same period in the previous year, the business posted $0.38 earnings per share. On average, research analysts predict that Sabra Healthcare REIT will post 1.52 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, November 30th. Investors of record on Friday, November 13th will be issued a $0.30 dividend. The ex-dividend date is Friday, November 13th. This represents a $1.20 dividend on an annualized basis and a yield of 5.8%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 428.57%.

Insider Transactions at Sabra Healthcare REIT

In other Sabra Healthcare REIT news, CEO Richard K. Matros sold 200,000 shares of the company’s stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $20.83, for a total transaction of $4,166,000.00. Following the completion of the sale, the chief executive officer directly owned 1,657,686 shares in the company, valued at $34,529,599.38. This represents a 10.77% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Foster sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, November 11th. The stock was sold at an average price of $20.98, for a total value of $209,800.00. Following the completion of the transaction, the director owned 72,834 shares in the company, valued at approximately $1,528,057.32. This trade represents a 12.07% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.09% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Sabra Healthcare REIT

Several hedge funds and other institutional investors have recently modified their holdings of the company. Lasalle Investment Management Securities LLC increased its position in Sabra Healthcare REIT by 8.2% during the 1st quarter. Lasalle Investment Management Securities LLC now owns 3,824,622 shares of the real estate investment trust’s stock worth $73,547,000 after purchasing an additional 290,405 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in Sabra Healthcare REIT by 7.8% during the first quarter. Dimensional Fund Advisors LP now owns 3,725,337 shares of the real estate investment trust’s stock valued at $71,640,000 after buying an additional 269,793 shares in the last quarter. Russell Investments Group Ltd. lifted its position in Sabra Healthcare REIT by 70.2% during the third quarter. Russell Investments Group Ltd. now owns 1,856,730 shares of the real estate investment trust’s stock valued at $36,615,000 after buying an additional 765,527 shares in the last quarter. Rush Island Management LP acquired a new position in Sabra Healthcare REIT during the first quarter valued at approximately $30,735,000. Finally, Sound Income Strategies LLC lifted its position in Sabra Healthcare REIT by 8.3% during the third quarter. Sound Income Strategies LLC now owns 1,051,751 shares of the real estate investment trust’s stock valued at $19,815,000 after buying an additional 80,453 shares in the last quarter. 99.40% of the stock is owned by institutional investors and hedge funds.

Sabra Healthcare REIT Company Profile

(Get Free Report)

Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in properties used to provide healthcare and senior living services. Its portfolio includes skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals. Sabra generally leases its properties to healthcare and senior living operators, providing real estate that supports their services. The company’s properties are located in the United States and Canada.

Further Reading

Analyst Recommendations for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.